TACHIFLUTASK 600 mg/10 mg Granulate

Зміст інструкції

1. TACHIFLUTASK 600 mg/10 mg granules for oral solution
   1. What is TACHIFLUTASK and what is it used for
   2. What you need to know before taking TACHIFLUTASK
   3. How to take TACHIFLUTASK
   4. Possible side effects
   5. How to store TACHIFLUTASK
   6. Contents of the pack and other information

TACHIFLUTASK 600 mg/10 mg granules for oral solution

Paracetamol/phenylephrine hydrochloride

Read this leaflet carefully before taking this medicine as it contains
important information for you.
Always take this medicine exactly as described in this leaflet or as your doctor or
pharmacist has told you.

• Keep this leaflet. You may need to read it again.
• If you want more information or advice, ask your pharmacist.
• If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
• See a doctor if you do not feel better or if your symptoms worsen after a short period of treatment.

Contents of this leaflet:

• 1. What TACHIFLUTASK is and what it is used for
• 2. What you need to know before you take TACHIFLUTASK
• 3. How to take TACHIFLUTASK
• 4. Possible side effects
• 5. How to store TACHIFLUTASK
• 6. Contents of the pack and other information

1. What is TACHIFLUTASK and what is it used for

TACHIFLUTASK is a medicine containing the active ingredients paracetamol and phenylephrine hydrochloride
which is used for the treatment of pain, fever and congestion.
TACHIFLUTASK is used for the short-term treatment of cold and
flu symptoms, including mild/moderate pain and fever, when associated with nasal congestion.
TACHIFLUTASK is indicated for adults and children over 12 years.
See a doctor if you do not feel better or if you feel worse after 3 days.

2. What you need to know before taking TACHIFLUTASK

Do not take TACHIFLUTASK

• if you are allergic to paracetamol, phenylephrine hydrochloride or any of the other ingredients of this medicine (listed in section 6);
• if you are taking beta-blockers (used to treat high blood pressure or heart disease);
• if you are taking tricyclic antidepressants (medicines used to treat depression);
• if you are taking monoamine oxidase inhibitors (medicines used to treat depression) or have taken them in the last two weeks;
• if you suffer from bronchial asthma;
• if you suffer from pheochromocytoma (a tumor of the adrenal glands);
• if you suffer from glaucoma (an eye condition often associated with increased intraocular pressure);
• if you are taking other sympathomimetic medicines (such as decongestants, appetite suppressants and psychostimulants similar to amphetamines);
• if you suffer from severe liver failure;
• if you have liver or kidney problems;
• if you suffer from diabetes;
• if you have an overactive thyroid (hyperthyroidism);
• if you have high blood pressure or heart or circulatory problems;
• if you have glucose-6-phosphate dehydrogenase deficiency (an inherited disease that leads to a decrease in red blood cell count);
• if you suffer from severe hemolytic anemia (abnormal breakdown of blood cells). Do not use the medicine in children under 12 years of age.

Warnings and precautions
Talk to your doctor or pharmacist before taking TACHIFLUTASK:

• if you are taking other medicines (see also “Other medicines and TACHIFLUTASK”);
• if you have an enlarged prostate gland;
• if you have an occlusive vascular disease (blockage of the arteries, e.g. Raynaud's syndrome);
• if you have reduced kidney function (TACHIFLUTASK contains sodium).

During treatment with TACHIFLUTASK, immediately inform your doctor if:
If you suffer from serious illnesses, including severe kidney impairment or sepsis (when bacteria and their
toxins circulate in the blood causing organ damage) or if you are malnourished, chronic alcoholism or if you are
also taking flucloxacillin (an antibiotic). In patients in these situations, a serious condition called metabolic acidosis (an abnormality of the blood and fluids) has been reported when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken in
association with flucloxacillin. Symptoms of metabolic acidosis may include: severe difficulty
breathing with rapid deep breathing, drowsiness, nausea and vomiting.
Do not use TACHIFLUTASK for more than 3 consecutive days without consulting a doctor.
Do not drink alcohol during treatment with TACHIFLUTASK.
If you are taking anti-inflammatory drugs, the use of TACHIFLUTASK is not recommended (see section 2
“Other medicines and TACHIFLUTASK”).
Do not take in association with other medicines containing paracetamol. If paracetamol is
taken in high doses, serious adverse reactions may occur, including severe liver damage and
alterations in the kidneys and blood.
Paracetamol may interfere with tests to determine blood sugar levels (in
people with diabetes) and uric acid levels (in people with gout).

Other medicines and TACHIFLUTASK
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
In particular, it is important to inform your doctor or pharmacist if you are taking any of the following
medicines:

• medicines that can alter liver function, such as zidovudine or isoniazid, which may increase the harmful effect of paracetamol on the liver;
• medicines that can alter the urinary excretion of paracetamol, such as probenecid;
• medicines that contain rifampicin (used in the treatment of tuberculosis), cimetidine (used in the treatment of stomach ulcers) or medicines such as glutethimide, phenobarbital, carbamazepine (used in the treatment of epilepsy); when taken together with paracetamol, these medicines must be used with extreme caution and under strict medical supervision;
• medicines used in the treatment of eye infections such as chloramphenicol;
• medicines used to delay blood clotting or prevent coagulation, e.g. warfarin, as paracetamol taken in high doses may lead to an increased risk of bleeding;
• medicines that can accelerate (e.g. metoclopramide, domperidone) or reduce/delay (e.g. cholestyramine, anticholinergics) the absorption of paracetamol;
• medicines used in the treatment of high blood pressure that contain beta-blockers;
• medicines that contain monoamine oxidase inhibitors (see also the section “Do not take TACHIFLUTASK”);
• medicines that contain tricyclic antidepressants or sympathetic amine mimetics;
• medicines prescribed for heart failure (digoxin);
• medicines used in the treatment of migraine such as ergotamine and methysergide;
• anti-inflammatory drugs;
• flucloxacillin (antibiotic), due to a serious risk of alterations in blood and fluids (called metabolic acidosis with high anion gap) which must be treated urgently. .

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before taking this medicine.
The use of TACHIFLUTASK is not recommended during pregnancy and breastfeeding; use TACHIFLUTASK
only after consulting your doctor.

Driving and using machines
TACHIFLUTASK does not impair your ability to drive or operate machinery. However, if you experience
dizziness, you should not drive or operate machinery.

TACHIFLUTASK contains sorbitol and aspartame:
This medicine contains:

• 42 mg of sorbitol per sachet;
• 25 mg of aspartame per sachet. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria, a rare genetic disorder that causes phenylalanine to build up because the body cannot process it properly

Sodium content
This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. essentially “sodium-free”.

3. How to take TACHIFLUTASK

Take this medicine following exactly as indicated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.

Dosage
Adults and children over 12 years: 1 sachet every 4-6 hours up to a maximum of 3 sachets in 24 hours.
Use in children
Use is contraindicated in children under 12 years of age.
Do not take more than the recommended dose without consulting your doctor.

Instructions for use
Place the granules directly on the tongue and swallow. TACHIFLUTASK dissolves with saliva: this allows its use without water.
You can also dissolve the contents of a sachet in a glass of hot (not boiling) water, mixing with a teaspoon. If desired, you can dilute with cold water to cool and sweeten.
Once prepared, drink the solution within a few minutes.

Warning:This product should be used for a short period of treatment.
Do not take for more than 3 consecutive days without consulting your doctor.
Consult your doctor if symptoms persist or if you notice any new change in their characteristics.

If you take more TACHIFLUTASK than you should
If you or someone else takes more TACHIFLUTASK than you should, or if you think a child has swallowed the contents of the sachet, go immediately to the nearest hospital or doctor, even if you feel well, and bring with you this leaflet, the remaining sachets and the box. In case of accidental intake of high doses of this medicine, paleness, nausea, vomiting, loss of appetite (anorexia), abdominal pain, alteration of blood sugar levels (glucose metabolism abnormalities) and accumulation of acids in the body (metabolic acidosis) may occur.
In severe poisoning, liver failure may be complicated by brain damage (encephalopathy, cerebral edema), blood loss (hemorrhage), reduced blood glucose (hypoglycemia), and death. Even in the absence of severe liver damage, a reduction in kidney function (acute renal failure) may occur, which manifests with kidney damage (acute tubular necrosis), blood loss in the urine (hematuria) and protein loss in the urine (proteinuria).
Heart rhythm disturbances (cardiac arrhythmias) and inflammation of the pancreas (pancreatitis) may also occur.
Irritability, headache (cephalalgia), and increased blood pressure may also occur. In the most severe cases, confusion, hallucinations and convulsions may occur. High doses of the medicine can cause a short-lived liquid diarrhea (transient osmotic diarrhea).
If you have any doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following list includes the side effects of paracetamol and phenylephrine.
The side effects are presented in order of decreasing frequency:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Not known: frequency cannot be estimated from available data.

Stop taking TACHIFLUTASK immediately and contact a doctor or go
immediately to hospital if you notice any of the following side effects:

• allergic reactions or hypersensitivity, anaphylactic shock (severe allergic reactions that cause difficulty breathing or dizziness);
• very rare cases of severe skin reactions have been reported: severe rash or exfoliation or mouth ulcers (toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme or polymorphous);
• breathing problems (bronchospasm). If you experience any of the following side effects, contact your doctor or pharmacist.Common (may affect up to 1 in 10 people):
• loss of appetite;
• nausea and vomiting. Rare (may affect up to 1 in 1,000 people):
• blood disorders that may appear as unexplained bruising, paleness or poor resistance to infection; decrease in specific blood cells (agranulocytosis, leucopenia, thrombocytopenia);
• tachycardia (increased heart rate), palpitations (feeling of beats in the chest);
• abnormal liver function (increased liver transaminases);
• hypersensitivity, including skin rashes, angioedema (sudden swelling of the skin and mucous membranes). Very rare (may affect up to 1 in 10,000 people):
• insomnia (difficulty sleeping), nervousness, anxiety, agitation, confusion, irritability;
• tremor (shaking), dizziness, headache;
• with prolonged use of high doses of paracetamol, interstitial nephritis (kidney inflammation) and adverse effects on the kidneys may occur. Not known (frequency cannot be estimated from the data

available):

• anemia (decrease in hemoglobin levels in the blood);
• mydriasis (pupil dilation), acute angle-closure glaucoma (an eye disease often associated with increased fluid pressure in the eye);
• laryngeal edema (swelling of the throat);
• diarrhea, gastrointestinal discomfort;
• liver diseases, hepatitis (yellowing of the skin and/or eyes);
• kidney disorders (worsening of renal failure), blood in the urine (hematuria);
• difficulty urinating (anuria, urinary retention);
• increased blood pressure (hypertension);
• severe condition that can make the blood more acidic (called metabolic acidosis), in patients with a serious illness who use paracetamol (see section 2)

Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your
doctor or pharmacist. You can also report side effects directly through the
national reporting system at www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
By reporting side effects you can help provide more information on the safety
of this medicine.

5. How to store TACHIFLUTASK

This medicine does not require any particular storage temperature.
Store in the original container to protect the medicine from humidity and light.
Do not use this medicine after the expiry date which is reported on the pack. The expiry date refers to the last day of that month.
It is important to always have the product information with you. Keep the package and leaflet.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. This will help protect the environment.
Keep this medicine out of the sight and reach of children.

6. Contents of the pack and other information

What TACHIFLUTASK contains
The active ingredients are: paracetamol 600 mg and phenylephrine hydrochloride 10 mg (equivalent to phenylephrine 8.2 mg).
The other ingredients are: mannitol (E 421), Xylitab 200 (xylitol, carboxymethylcellulose), lemon aroma,
sorbitol (E 420) ascorbic acid, citric acid, hydrated colloidal silica, aspartame (E 951)
sodium saccharin.

Description of the appearance of TACHIFLUTASK and contents of the pack
TACHIFLUTASK is presented in sachets containing granules ranging in colour from white to ivory.
TACHIFLUTASK is available in packs of 10 and 16 sachets.

Marketing Authorisation Holder
Angelini Pharma S.p.A. - Viale Amelia, 70 – 00181 ROMA

Manufacturer
E-Pharma Trento S.p.A. – Via Provina, 2 – 38123 Trento (TN)